TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 2 Stories That Have Flown Under the Radar

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is fighting a multi-front war.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 Lessons From Bill Ackman’s Painful Experience

    Bill Ackman has made mistakes with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that the rest of us can learn from.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown…

    Read more »

    The Motley Fool
    Investing

    Is Concordia Healthcare Corp. or Valeant Pharmaceuticals Intl Inc. the Better Buy?

    Investors could potentially make huge gains from Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), but which is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Why Analysts Still Have a +$90 Price Target

    Analysts still are very bullish on Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Is something else going on here?

    Read more »

    The Motley Fool
    Investing

    The Epic Collapse of Valeant Pharmaceuticals Intl Inc. Continues

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have now fallen nearly 50% in the past week, prompting many investors to…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Dig Itself out of its Financial Hole?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in danger of defaulting on its debt.

    Read more »

    The Motley Fool
    Investing

    Sell and Avoid Valeant Pharmaceuticals Intl Inc.

    Because of negative situations, investors should flee Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and avoid it for good.

    Read more »

    The Motley Fool
    Investing

    Why Bill Ackman Makes Valeant Pharmaceuticals Intl Inc. Shareholders Nervous

    Pershing Square may have to sell shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), driving the shares down further.

    Read more »

    The Motley Fool
    Investing

    Why My Price Target for Valeant Pharmaceuticals Intl Inc. Is $0

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) should not be bought at any price.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 Things to Look for as it Reports 4th-Quarter Numbers

    After two delays, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will finally report fourth-quarter results on Tuesday.

    Read more »